Status:
COMPLETED
Effects of Topical Cream for Pain Relief
Lead Sponsor:
Natural Immune Systems Inc
Conditions:
Chronic Pain
Eligibility:
All Genders
21-75 years
Phase:
NA
Brief Summary
To perform a clinical proof-of-concept study on a novel topical formula for pain relief.
Detailed Description
An open-label study where each participant will be involved in the study for 4 weeks. During the study participants will use the topical cream 1-2 times daily on the anatomical area(s) causing the mos...
Eligibility Criteria
Inclusion
- BMI between 18.5 and 34.9 kg/m2 (inclusive)
- Chronic joint/muscle related pain for at least past 6 months
- Experiencing chronic pain in at least one specific anatomical area for more than 6 months.
Exclusion
- Cancer during past 12 months
- Chemotherapy during past 12 months
- Currently taking prescription pain medications
- Getting regular joint injections (such as cortisone shots);
- Immunization during last month
- Participation in another clinical trial study during this trial, involving an investigational product or lifestyle change
- Regularly experiencing headaches, including migraines
- Serious active illness within past 6 months
- Significant active uncontrolled illness (such as lymphoma, liver disease, kidney failure, heart failure).
- Skin allergies related to ingredients in test product.
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05213052
Start Date
August 1 2021
End Date
May 1 2022
Last Update
June 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gitte Jensen
Klamath Falls, Oregon, United States, 97601-5904